Effect of dialysis dose and membrane flux in maintenance hemodialysis

New England Journal of Medicine

Volumn 347, Issue 25, 2002, Pages 2010-2019

  Eknoyan, Garabed ^a   Beck, Gerald J ^b   Cheung, Alfred K ^c   Daugirdas, John T ^d   Greene, Tom ^b   Kusek, John W ^e   Allon, Michael ^f   Bailey, James ^g   Delmez, James A ^h   Depner, Thomas A ⁱ   Dwyer, Johanna T ^j   Levey, Andrew S ^j   Levin, Nathan W ^k   Milford, Edgar ^l   Ornt, Daniel B ^m   Rocco, Michael V ⁿ   Schulman, Gerald ^o   Schwab, Steve J ^p   Teehan, Brendan P ^q   Toto, Robert ^r  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF UTAH   (United States)

^d UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^e NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^f UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^g EMORY UNIVERSITY HOSPITAL   (United States)

^h WASHINGTON UNIVERSITY   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j TUFTS MEDICAL CENTER   (United States)

^k BETH ISRAEL MEDICAL CENTER   (United States)

^l BRIGHAM AND WOMEN S HOSPITAL   (United States)

^m UNIVERSITY OF ROCHESTER   (United States)

ⁿ WAKE FOREST UNIVERSITY   (United States)

^o VANDERBILT UNIVERSITY   (United States)

^p DUKE UNIVERSITY   (United States)

^q LANKENAU HOSPITAL   (United States)

^r UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; SERUM ALBUMIN; UREA;

ADULT; AGED; ARTICLE; CAUSE OF DEATH; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DIALYSIS MEMBRANE; FACTORIAL ANALYSIS; FEMALE; HEART DISEASE; HEMODIALYSIS; HOSPITALIZATION; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; MULTICENTER STUDY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK; TREATMENT INDICATION; TREATMENT OUTCOME; UNITED STATES; VASCULAR ACCESS;

ADULT; AGED; FEMALE; HEMODIALYSIS SOLUTIONS; HOSPITALIZATION; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MEMBRANES, ARTIFICIAL; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RENAL DIALYSIS; SURVIVAL ANALYSIS; UREA;

EID: 0037137562     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa021583     Document Type: Article

References (37)

1. Renal Data System. USRDS 2001 annual data report: atlas of end-stage renal disease in the United States. Bethesda, Md.: National Institute of Diabetes and Digestive and Kidney Diseases, 2001.
2. Owen WF Jr, Lew NL, Liu Y, Lowrie EG, Lazarus JM. The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med 1993;329:1001-6.
3. Gotch FA, Sargent JA. A mechanistic analysis of the National Cooperative Dialysis Study (NCDS). Kidney Int 1985;28:526-34.
4. Eknoyan G, Levin N. NKF-K/DOQI clinical practice guidelines: Update 2000. Am J Kidney Dis 2001;37:Suppl 1:S5-S6. [Erratum, Am J Kidney Dis 2001;38:917.]
5. Daugirdas JT, Depner TA, Gotch FA, et al. Comparison of methods to predict equilibrated Kt/V in the HEMO Pilot Study. Kidney Int 1997;52: 1395-405.
6. Lowrie EG, Laird NM, Parker TF, Sargent JA. Effect of the hemodialysis prescription on patient morbidity: report from the National Cooperative Dialysis Study. N Engl J Med 1981;305:1176-81.
7. Shinzato T, Nakai S, Akiba T, et al. Survival in long-term haemodialysis patients: Results from the annual survey of the Japanese Society for Dialysis Therapy. Nephrol Dial Transplant 1997;12:884-8.
8. Wolfe RA, Ashby VB, Daugirdas JT, Agodoa LY, Jones CA, Port FK. Body size, dose of hemodialysis, and mortality. Am J Kidney Dis 2000;35: 80-8.
9. Port FK, Ashby VB, Dhingra RK, Roys EC, Wolfe RA. Dialysis dose and body mass index are strongly associated with survival in hemodialysis patients. J Am Soc Nephrol 2002;13:1061-6.
10. Held PJ, Port FK, Wolfe RA, et al. The dose of hemodialysis and patient mortality. Kidney Int 1996;50:550-6.
11. Locatelli F, Marcelli D, Conte F, Limido A, Malberti F, Spotti D. Comparison of mortality in ESRD patients on convective and diffusive extracorporeal treatments: The Registro Lombardo Dialisi E Trapianto. Kidney Int 1999;55:286-93.
12. Port FK, Wolfe RA, Hulbert-Shearon TE, et al. Mortality risk by hemodialyzer reuse practice and dialyzer membrane characteristics: Results from the USRDS dialysis morbidity and mortality study. Am J Kidney Dis 2001;37:276-86.
13. Eknoyan G, Levey AS, Beck GJ, et al. The Hemodialysis (HEMO) Study: Rationale for selection of interventions. Semin Dial 1996;9:24-33.
14. Greene T, Beck GJ, Gassman JJ, et al. Design and statistical issues of the Hemodialysis (HEMO) Study. Control Clin Trials 2000;21:502-25.
15. Depner TA. Prescribing Hemodialysis: A Guide to Urea Modeling. Dordrecht, the Netherlands: Kluwer Academic, 1991.
16. Daugirdas JT, Schneditz D. Overestimation of hemodialysis dose depends on dialysis efficiency by regional blood flow but not by conventional two pool urea kinetic analysis. ASAIO J 1995;41:M719-M724.
17. Leypoldt JK, Cheung AK, Deeter RB. Single compartment models for evaluating beta 2-microglobulin clearance during hemodialysis. ASAIO J 1997;43:904-9.
18. Cheung AK, Agodoa LY, Daugirdas JT, et al. Effects of hemodialyzer reuse on clearances of urea and beta2-microglobulin. J Am Soc Nephrol 1999;10:117-27.
19. HEMO Study protocol. Bethesda, Md.: National Institute of Diabetes and Digestive and Kidney Diseases, June 1999.
20. Miskulin DC, Athienites NV, Yan G, et al. Comorbidity assessment using the Index of Coexistent Diseases in a multicenter clinical trial. Kidney Int 2001;60:1498-510.
21. Rocco MV, Yan G, Gassman J. Comparison of causes of death using HEMO Study and HCFA end-stage renal disease death notification classification systems. Am J Kidney Dis 2002;39:146-53.
22. Cox DR. Regression models and life-tables. J R Stat Soc [B] 1972;34: 187-220.
23. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
24. McCullagh P, Nelder JA. Generalized Linear Models. 2nd Ed. London: Chapman & Hall, 1989.
25. O'Brien PC, Fleming TR. A multiple testing procedure for clinical trials. Biometrics 1979;35:549-56.
26. Renal Data System. USRDS 2000 Annual Data Report: Atlas of End-stage Renal Disease in the United States. Bethesda, Md.: National Institute of Diabetes and Digestive and Kidney Diseases, 2000 (table H.5).
27. Li Z, Lew NL, Lazarus JM, Lowrie EG. Comparing the urea reduction ratio and the urea product as outcome-based measures of hemodialysis dose. Am J Kidney Dis 2000;35:598-605.
28. The justification for randomized controlled trials. In: Pocock SJ. Clinical Trials: A Practical Approach. New York: John Wiley, 1983:50-65.
29. Dunn D, Babiker A, Hooker M, Darbyshire J. The dangers of inferring treatment effects from observational data: A case study in HIV infection. Control Clin Trials 2002;23:106-10.
30. Hornberger JC, Chernew M, Petersen J, Garber AM. A multivariate analysis of mortality and hospital admissions with high-flux dialysis. J Am Soc Nephrol 1992;3:1227-37
31. Owen WF Jr, Chertow GM, Lazarus JM, Lowrie EG. Dose of hemodialysis and survival: Differences by race and sex. JAMA 1998;280:1764-8.
32. Lowrie EG, Chertow GM, Lew NL, Lazarus JM, Owen WF. The urea [clearance x dialysis time] product (Kt) as an outcome-based measure of hemodialysis dose. Kidney Int 1999;56:729-37.
33. Collins AJ, Ma JZ, Umen A, Keshaviah P. Urea index and other predictors of hemodialysis patient survival. Am J Kidney Dis 1994;23:272-82. [Erratum, Am J Kidney Dis 1994;24:157.]
34. Mohr PE, Neumann PJ, Franco SJ, Marainen J, Lockridge R, Ting G. The case for daily dialysis: Its impact on costs and quality of life. Am J Kidney Dis 2001;37:777-89.
35. Vos PF, Zilch O, Kooistra MP. Clinical outcome of daily dialysis. Am J Kidney Dis 2001;37:Suppl 2:S99-S102.
36. Ward RA, Schmidt B, Hullin J, Hillebrand GF, Samtleben W. A comparison of on-line hemodiafiltration and high-flux hemodialysis: A prospective clinical study. J Am Soc Nephrol 2000;11:2344-50.
37. Winchester JF. Sorbent hemoperfusion in end-stage renal disease: An in-depth review. Adv Ren Replace Ther 2002;9:19-25.